Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01116037 · ClinicalTrials.gov registry record · NA
ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study
A NA study, sponsored by Medtronic Cardiovascular.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01116037 is a NA study that was terminated before completion, run by Medtronic Cardiovascular. The registered enrollment target is 26 participants.
The verdict
NCT01116037, a NA study, was terminated before completion, sponsored by Medtronic Cardiovascular.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to determine if there is an increased incidence and rate of aortic regurgitation in younger (\</= 70 years of age) patients implanted with the Model 1000 and undergoing isolated aortic valve replacement of his/her native aortic valve, or replacement of a failed prosthesis.
Interventions
- DEVICE ATS 3f Aortic Bioprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2009-09 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01116037
The ClinicalTrials.gov registry entry for NCT01116037 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ATS 3f Aortic Bioprosthesis is the first listed.
NCT01116037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01116037 about?
NCT01116037 is a clinical study titled "ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study". The purpose of this clinical study is to determine if there is an increased incidence and rate of aortic regurgitation in younger (\</= 70 years of age) patients implanted with the Model 1000 and undergoing isolated aortic valve replacement of his/her native aortic valve, or replacement of a failed ...
What is the current status of trial NCT01116037?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2009-09. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01116037?
The interventions under investigation include: ATS 3f Aortic Bioprosthesis (DEVICE).
Who is sponsoring clinical trial NCT01116037?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.